MANILA – The Philippine Health Insurance Corporation (PhilHealth) on Sunday clarified that the suspension of the Interim Reimbursement Mechanism (IRM) will not affect the availment of Covid-19 benefits or any of its regular benefits by its members.
In a statement, PhilHealth said the IRM suspension “will give way for its review in light of the recent Senate and congressional hearings”.
Through its Covid-19 benefit packages, PhilHealth has assured coverage for patients who need hospitalization, SARS CoV-2 testing and community isolation.
It reaffirmed the legality and necessity of the IRM in the country’s overall Covid-19 response.
“The releases follow the strict rules as stated in its Circular No. 2020-0007 which specifies the process by which IRM funding can be obtained by the healthcare facilities. PhilHealth strongly dismisses allegations of ‘favoritism’ in the disbursement of IRM funds,” the agency said.
It also acknowledged the continuing clamor of hospitals for the reinstatement of the IRM.
“We vow to continue working with the legislators and all the investigating bodies in order to address all of their concerns,” it added. (PNA)